NCT00067990
Angiotensin II Blockade for Chronic Allograft Nephropathy
See it on ClinicalTrials.gov ↗153 people
38.6%
61.4%
59 womenmiddle line = equal numbers94 men
- Phase
- PHASE4
- Paid for by
- University of Minnesota
- Finished
- 2011-06
- Health conditions
- Kidney Disease, Proteinuria
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 48.7 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 86.9% · Other 13.1%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Women of childbearing age who wish to become pregnant and/or are unwilling to use contraceptive measures or who are pregnant.”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Women of childbearing age who wish to become pregnant and/or are unwilling to use contraceptive measures or who are pregnant.”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Recipients whose primary renal disease is primary hyperoxaluria,dense-deposit disease, focal segmental glomerulosclerosis or hemolytic uremic syndrome.”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Recipients who are \> 55 years old and had a history of cardiovascular disease (coronary artery disease, stroke or peripheral vascular disease).”
Study titles and rules are shown in their original English.